Exhibition Project of Bio Island Science and Culture Museum

Guangzhou Phar. Holdings is the world's first enterprise to enter the Fortune Global 500 with traditional Chinese medicine as its main business. It has more than 30 member companies, including 12 Chinese time-honored enterprises such as Chen Liji, the "world's oldest pharmaceutical factory" with a history of more than 420 years, 10 century old stores, and 6 national intangible cultural heritage projects. The adherence to tradition and innovation in traditional Chinese medicine have distinct characteristics in the corporate culture of Guangzhou Pharmaceutical.

The plan is based on the unique corporate culture characteristics of Guangzhou Phar. Holdings, and includes several chapters on life culture, life technology, and life integration. With the three major genes of red, innovation, and longevity of Guangzhou Pharmaceutical as the background, and the innovation of traditional Chinese medicine as the context, it showcases the industrial characteristics, responsibilities, and commitment of Guangzhou Pharmaceutical as the largest pharmaceutical enterprise group in the country.

The General Secretary mentioned: "We should adhere to the principle of people first and life first, develop and produce more" Chinese medicine "suitable for the inheritance of Chinese people's life genes and physical fitness characteristics, and especially strengthen the inheritance, innovation and development of traditional Chinese medicine."Based on this, we will apply the concepts of safeguarding people's health and protecting life to the design concept. We believe that the process of life evolution represents the spirit of inheritance and innovation of Guangzhou Phar. Holdings. Therefore, while fully utilizing the architectural features, we have created a new connecting space for the Life Innovation Hall of Guangzhou Phar. Holdings, constructing themed spaces such as "Life Culture", "Life Technology", "Life Integration", and "LIFE+", and building a new future that can understand the big health industry.